|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| C07K 14/605 | (2006.01) |
| (11) | Number of the document | 3368060 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16785667.3 |
| Date of filing the European patent application | 2016-10-14 | |
| (97) | Date of publication of the European application | 2018-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-24 |
| (46) | Date of publication of the claims translation | 2020-08-25 |
| (86) | Number | PCT/US2016/056959 |
| Date | 2016-10-14 |
| (87) | Number | WO 2017/074714 |
| Date | 2017-05-04 |
| (30) | Number | Date | Country code |
| 201562246199 P | 2015-10-26 | US |
| (72) |
COSKUN, Tamer, US
ALSINA-FERNANDEZ, Jorge, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Gliukagono receptoriaus antigonistai |
| GLUCAGON RECEPTOR AGONISTS |
| Payment date | Validity (years) | Amount | |
| 2022-09-20 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-10-14 |